Fig. 1From: Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)Overall survival of (A) the entire cohort: 13.6 months (95% CI: 7.5–16.1 months), (B) the 3 subgroups (C) child Pugh A versus Child Pugh B/C patients (D) with versus without portal vein thrombosis (E) with Eastern Cooperative Oncology Group performance scores of 0 versus 1 versus 2 or greaterBack to article page